11 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/19/23 10:59
12/18/23
VNRXHealthDiagnIn Vitro & In Vivo DiagnosticButera Salvatore ThomasNVOCEO - Vo5P501.0404821278D
12/14/23 09:11
12/13/23
VNRXHealthDiagnIn Vitro & In Vivo DiagnosticRootsaert Rodney GerardNVOSecretar1P60.600001011,086D
12/11/23 08:51
12/8/23
VNRXHealthDiagnIn Vitro & In Vivo DiagnosticReynolds Cameron JohnNVDOP,CEO2P190.945002012,746D
11/28/23 09:39
11/27/23
VNRXHealthDiagnIn Vitro & In Vivo DiagnosticInnes Guy ArchibaldNVD4P4471.570284122,601D
11/28/23 09:39
11/27/23
VNRXHealthDiagnIn Vitro & In Vivo DiagnosticFutcher EdwardNVD2P130.95000143428D
9/19/23 16:05
8/31/23
VNRXHealthDiagnIn Vitro & In Vivo DiagnosticHenshall MickieNVD1P51.25042519D
9/6/23 10:01
9/5/23
VNRXHealthDiagnIn Vitro & In Vivo DiagnosticBarnes PhillipNVD1P71.30052525D
9/1/23 09:41
8/31/23
VNRXHealthDiagnIn Vitro & In Vivo DiagnosticFaulkes Martin CharlesNVD1P121.2801002,030D
8/31/23 09:35
8/29/23
VNRXHealthDiagnIn Vitro & In Vivo DiagnosticMicallef Jacob VincentNVOChief Sc2P.m501.2504014328I
8/25/23 11:49
8/24/23
VNRXHealthDiagnIn Vitro & In Vivo DiagnosticKway JasmineNVOCEO - Si1P61.2005687I
8/24/23 12:00
8/24/23
VNRXHealthDiagnIn Vitro & In Vivo DiagnosticMichel GaetanNVOCOO1P61.23052213D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact